These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613 [TBL] [Abstract][Full Text] [Related]
3. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Guerrero AT; Zarpelon AC; Vieira SM; Pinto LG; Ferreira SH; Cunha FQ; Verri WA; Cunha TM Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):51-9. PubMed ID: 23187752 [TBL] [Abstract][Full Text] [Related]
4. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation. Yamaguchi M; Matsui M; Higa R; Yamazaki Y; Ikari A; Miyake M; Miwa M; Ishii S; Sugatani J; Shimizu T Biochem Pharmacol; 2015 Feb; 93(4):482-95. PubMed ID: 25577975 [TBL] [Abstract][Full Text] [Related]
5. Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis. Vilela MC; Lima GK; Rodrigues DH; Lacerda-Queiroz N; Pedroso VS; de Miranda AS; Rachid MA; Kroon EG; Campos MA; Teixeira MM; Teixeira AL J Neuroimmune Pharmacol; 2016 Dec; 11(4):613-621. PubMed ID: 27193134 [TBL] [Abstract][Full Text] [Related]
6. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Souza DG; Pinho V; Soares AC; Shimizu T; Ishii S; Teixeira MM Br J Pharmacol; 2003 Jun; 139(4):733-40. PubMed ID: 12812996 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Doi K; Okamoto K; Negishi K; Suzuki Y; Nakao A; Fujita T; Toda A; Yokomizo T; Kita Y; Kihara Y; Ishii S; Shimizu T; Noiri E Am J Pathol; 2006 May; 168(5):1413-24. PubMed ID: 16651609 [TBL] [Abstract][Full Text] [Related]
8. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. Sahu RP; Kozman AA; Yao Y; DaSilva SC; Rezania S; Martel KC; Warren SJ; Travers JB; Konger RL Carcinogenesis; 2012 Mar; 33(3):694-701. PubMed ID: 22223848 [TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract. Branger J; Wieland CW; Florquin S; Maris NA; Pater JM; Speelman P; Shimizu T; Ishii S; van der Poll T Shock; 2004 Dec; 22(6):543-7. PubMed ID: 15545826 [TBL] [Abstract][Full Text] [Related]
10. PAFR in adipose tissue macrophages is associated with anti-inflammatory phenotype and metabolic homoeostasis. Filgueiras LR; Koga MM; Quaresma PG; Ishizuka EK; Montes MB; Prada PO; Saad MJ; Jancar S; Rios FJ Clin Sci (Lond); 2016 Apr; 130(8):601-12. PubMed ID: 26785675 [TBL] [Abstract][Full Text] [Related]
11. Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. Moreno SE; Alves-Filho JC; Rios-Santos F; Silva JS; Ferreira SH; Cunha FQ; Teixeira MM J Immunol; 2006 Jul; 177(2):1264-71. PubMed ID: 16818786 [TBL] [Abstract][Full Text] [Related]
12. Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor. da Silva Junior IA; Stone SC; Rossetti RM; Jancar S; Lepique AP J Immunol Res; 2017; 2017():5482768. PubMed ID: 29445756 [TBL] [Abstract][Full Text] [Related]
13. Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor-deficient mice with age. Sugatani J; Sadamitsu S; Yamaguchi M; Yamazaki Y; Higa R; Hattori Y; Uchida T; Ikari A; Sugiyama W; Watanabe T; Ishii S; Miwa M; Shimizu T FASEB J; 2014 Jan; 28(1):440-52. PubMed ID: 24100020 [TBL] [Abstract][Full Text] [Related]
14. Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects. Tian Z; Chu T; Shields LBE; Zhu Q; Zhang YP; Kong M; Barnes GN; Wang Y; Shields CB; Cai J Mol Neurobiol; 2020 Oct; 57(10):4069-4081. PubMed ID: 32661728 [TBL] [Abstract][Full Text] [Related]
15. Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor. Wang Y; Gao Z; Zhang Y; Feng SQ; Liu Y; Shields LBE; Zhao YZ; Zhu Q; Gozal D; Shields CB; Cai J Mol Neurobiol; 2016 Jul; 53(5):3448-3461. PubMed ID: 26084439 [TBL] [Abstract][Full Text] [Related]
16. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. Kihara Y; Ishii S; Kita Y; Toda A; Shimada A; Shimizu T J Exp Med; 2005 Sep; 202(6):853-63. PubMed ID: 16172262 [TBL] [Abstract][Full Text] [Related]
18. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. Rijneveld AW; Weijer S; Florquin S; Speelman P; Shimizu T; Ishii S; van der Poll T J Infect Dis; 2004 Feb; 189(4):711-6. PubMed ID: 14767826 [TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor. Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558 [TBL] [Abstract][Full Text] [Related]
20. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. Knapp S; von Aulock S; Leendertse M; Haslinger I; Draing C; Golenbock DT; van der Poll T J Immunol; 2008 Mar; 180(5):3478-84. PubMed ID: 18292574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]